亚洲糖蛋白受体1促进了SARS-CoV-2感染人类正常肝细胞的发生

Xinyi Yang1, Xu Zheng2, Yuqi Zhu1

  • 1State Key Laboratory of Genetic Engineering and Engineering Research Center of Gene Technology, Ministry of Education, Institute of Genetics, School of Life Sciences, Yiwu Research Institute, Fudan University, Shanghai, China.

概括

亚洲糖蛋白受体1 (ASGR1) 促进SARS-CoV-2进入肝细胞,独立于ACE2. 抑制ASGR1显著减少肝细胞中的病毒感染,确定它是SARS-CoV-2的关键入口受体.